The U.S. is suffering from a critical shortage of generic medicine thanks to the pandemic. The U.S. government is making a huge investment into Kodak to increase production of these key drugs. Dean Fanelli, partner at Seyfarth Shaw LLP, joined Cheddar to discuss.